Image of Andy Porter

Andy Porter

Director @ NovaBiotics Ltd

Director - Chief Technical Officer at Elasmogen Ltd

Aberdeen, United Kingdom

Ranked #873 out of 17,460 for Director in United States

Section title

Andy Porter's Email Addresses & Phone Numbers

Andy Porter's Work Experience

NovaBiotics Ltd


May 2009 to Present

Monkey Bars Ltd


April 2009 to Present

Grampian Bio-Partners Ltd


March 2008 to Present

Andy Porter's Education

University of St. Andrews

Bachelor of Science (BSc)

1980 to 1984

The University of Reading

Doctor of Philosophy (PhD)

1984 to 1987

Oldham Hulme Grammar School

1969 to 1980

Andy Porter's Professional Skills Radar Chart

Based on our findings, Andy Porter is ...

Big picture

What's on Andy Porter's mind?

Based on our findings, Andy Porter is ...

52% Left Brained
48% Right Brained

Andy Porter's Estimated Salary Range

About Andy Porter's Current Company

NovaBiotics Ltd

12th June 2015: Phase IIa clinical study results for Lynovex® (NM001) presented at the 38th Annual European Cystic Fibrosis Symposium Clinical data supports the application of Lynovex® as a novel treatment for the infectious exacerbations associated with cystic fibrosis January 2015 – NovaBiotics Ltd announces that Woodford Investment Management LLP has invested £5.0 million in a private...

Frequently Asked Questions about Andy Porter

What company does Andy Porter work for?

Andy Porter works for NovaBiotics Ltd

What is Andy Porter's role at NovaBiotics Ltd?

Andy Porter is Director

What is Andy Porter's personal email address?

Andy Porter's personal email address is an****[email protected]

What is Andy Porter's business email address?

Andy Porter's business email address is a****[email protected]

What is Andy Porter's Phone Number?

Andy Porter's phone +44 ** **** *234

What industry does Andy Porter work in?

Andy Porter works in the Biotechnology industry.

About Andy Porter

📖 Summary

Professor of Biotechnology and Director of the Scottish Biologics Facility (SBF), University of Aberdeen. Currently actively commercialising a new SBF biologics platform based on shark VNAR single-domains with a focus in inflammation and oncology. This new University spin-out will be called Elasmogen Ltd. Founder and CSO of Haptogen Ltd, acquired by Wyeth Inc in October 2007. In 2005 became the Ernst and Young Plc, UK’s Science and Technology Entrepreneur of the Year. A Fellow of the Royal Society of Edinburgh since 2006 and a Fellow of the Society of Biology since 2012. I continue to hold a number of non-executive Board positions within the Scottish biotechnology sector and have previously been part of commercial teams (consultant or NED) that have progressed protein based drugs into late stage clinical trials including Bioven Europe Ltd and their Phase 3 clinical trial for lung cancer (August 2012). Unusually for an academic I also part own an award winning cocktail bar “Orchid” voted the “best cocktail bar in Scotland” at the Scottish Licence Trade awards dinner 2012 and an award winning Japanese restaurant call Yatai voted Scottish "Oriental" restaurant of the year in 2013.Director @ 12th June 2015: Phase IIa clinical study results for Lynovex® (NM001) presented at the 38th Annual European Cystic Fibrosis Symposium Clinical data supports the application of Lynovex® as a novel treatment for the infectious exacerbations associated with cystic fibrosis January 2015 – NovaBiotics Ltd announces that Woodford Investment Management LLP has invested £5.0 million in a private placement. The funds will provide working capital to enable NovaBiotics to achieve key value enhancing milestones in the short to mid-term. The priority for the business is driving forward the Company’s clinical stage, first-in-class antimicrobial therapeutics assets. October 2014: Dr. Deborah O’Neil, the Company’s Chief Executive Officer, was named Ernst and Young UK Health Products & Services Entrepreneur of the Year 2014 at their awards dinner in London NovaBiotics Ltd, announced (Sept 2014) that the US Food and Drug Administration (FDA) has granted orphan drug designation for Lynovex® (NM001), the Company’s first-in-class therapeutic candidate for the treatment of Cystic Fibrosis (CF). Dr Deborah O'Neil (CEO) wins Ernst and Young Scottish Entrepreneur of the Year and Grampian Entrepreneur of the Year in July 2014. NovaBiotics wins the Scottish Life Science Business Leadership award Feb 2014 NovaBiotics announced that it has partnered with the Cystic Fibrosis Trust and Health Sciences Scotland, for a Phase1/2a clinical trial of its novel compound, Lynovex® Dec 2013. First patients recruited into trial July 2014. NovaBiotics entered into an agreement with Taro Pharmaceuticals North America, Inc. August 2013 Licensing and co-development agreement for the anti-fungal peptide treatment, Novexatin® From May 2009 to Present (6 years 8 months) Director @ 27th November 2015: Porter's Gin open for business at A trio of award-winning, trade professionals have become the first to start distilling in Aberdeen city centre for 100 years. Founders Ben Iravani, Josh Rennie and Alex Lawrence have spent the past few years fine-tuning their gin – undertaking hundreds of small scale distillations in order to perfect their method and recipe. They have been working closely with the UK's oldest distillers G&J in a collaboration to bring a premium gin to the market this Xmas. The result is the flagship Porter’s Gin, an aromatic and flavoursome spirit . June 2014: Managing Director, Ben Iravani wins Grampian's Young Entrepreneur of the Year April 2014: Not one but two members of the team (Alex from Orchid; Sian for Bar 99 and Kitchen) make the last 15 finals of UK Mixologist of the year in London. Alex Laurence goes on to win pushing the Ritz Hotel into second place. His prize an all expenses paid, 4 week trip to Columbia ! Orchid wins bar of the year at the Aberdeen/Aberdeenshire tourism awards March 2014. Four members of the Monkey Bars Ltd team are through to different Scottish and UK finals in Mixology and Bar Personality of the Year 2014. Monkey Bars Ltd purchased a new venue "Bar 99" in Aberdeen. New refurb and launching of our new food offering Feb 2014. Orchid is shortlisted for two Scottish License Trade Awards, 2013. Yatai is recommended by the Michelin Guide Dec 2013. Orchid increases its "back-bar" offering by 75 new spirits Jan 2014. Orchid wins Scottish Cocktail Bar of the Year 2012 in SLTN awards. Yatai wins Scottish Oriental Restaurant of the Year 2013. From April 2009 to Present (6 years 9 months) Director @ From March 2008 to Present (7 years 10 months) Chair @ From March 2011 to Present (4 years 10 months) Director Scottish Biologics Facility @ From January 2008 to Present (8 years) Professor of Biotechnology @ From March 1991 to Present (24 years 10 months) Director @ Sept 2014: Scottish life sciences company Pharmacells today said it was planning to accelerate stem cell therapy trials and create 12 jobs following its acquisition by London-based Precious Cells. The additional jobs will be created at its BioCity base at Newhouse near Glasgow. Precious Cells BioBank’s acquisition of stem cell tech Pharmacells is first deal in the sector in the UK. 15th July 2014: UK-based international provider of stem cell technologies Precious Cells BioBank has agreed terms to acquire stem cell technology specialist Pharmacells Group. This deal will provide Precious Cells BioBank with its own proprietary adult blood stem cell technology platform. From July 2010 to July 2013 (3 years 1 month) Bachelor of Science (BSc) @ University of St. Andrews From 1980 to 1984 Doctor of Philosophy (PhD) @ The University of Reading From 1984 to 1987 Oldham Hulme Grammar School From 1969 to 1980 Andy Porter is skilled in: Entrepreneurship, Science, Protein Chemistry, Biotechnology, Clinical Trials, Lifesciences, Drug Discovery, Biochemistry, Cell Biology, Molecular Biology, Technology Transfer, Cell, Cell Culture, Genomics, Drug Development, Pharmacology, Life Sciences

Andy Porter’s Personal Email Address, Business Email, and Phone Number

are curated by ContactOut on this page.

10x your recruitment & sales conversations

Contact over 200M professionals
instantly by email or phone. Reveal
personal & work email addresses, as
well as phone numbers accurately with
our ContactOut Chrome extension.

In a nutshell

Andy Porter's Personality Type

Extraversion (E), Sensing (S), Feeling (F), Judging (J)

Average Tenure

8 year(s), 10 month(s)

Andy Porter's Willingness to Change Jobs



Open to opportunity?

There's 79% chance that Andy Porter is seeking for new opportunities

Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 400K users from

76% of Fortune 500 companies

Microsoft Nestle PWC JP Morgan Merck Rackspace WarnerMedia Randstad Yelp Google

The most accurate data ever

CCPA Compliant
GDPA Aligned
150M Personal Emails
300M Work Emails
50M Direct Dials
200M Professional Profiles
30M Company Profiles

Hire Anyone, Anywhere
with ContactOut today

Making remote or global hires? We can help.

  • 50 contacts/month
  • Works on standard LinkedIn only
  • Work emails, personal emails, mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free